Literature DB >> 16118671

Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.

Erika L Barr1, Sander Ouburg, Joseph U Igietseme, Servaas A Morré, Edith Okwandu, Francis O Eko, Godwin Ifere, Tesfaye Belay, Qing He, Deborah Lyn, Gift Nwankwo, James W Lillard, Carolyn M Black, Godwin A Ananaba.   

Abstract

T cell immunity protects against diseases caused by the obligate intracellular bacterium Chlamydia trachomatis. Incidentally, host inflammatory response that includes T cells appears to also contribute to the pathogenesis of chlamydial diseases such as trachoma and tubal factor infertility (TFI). Therefore, designing effective prevention strategies requires a delineation of immune processes responsible for pathology and those mediating immunity, and identification of the immunogenetic factors predisposing to complication development. The chemokine receptor CCR5 is crucial for T cell activation and function since its deficiency causes suppression of T cell response. We investigated the hypothesis that the clearance of genital chlamydial infection in CCR5-deficient mice could be delayed in the short term; however, a beneficial effect could include protection against inflammation-related complications such as TFI. In a translational study in humans, we investigated the effect of a functional 32 bp deletion in the CCR5 gene on the risk of developing tubal pathology in Dutch Caucasian women with immunologic evidence [i.e., immunoglobulin G (IgG) responses] of chlamydial infection. When genitally-infected wild-type (WT) and CCR5 knockout (CCR5KO) mice were evaluated for microbiologic shedding of chlamydiae, there was a greater intensity of infection and delayed resolution in the knockout mice. However, compared to WT mice, the fertility of infected CCR5KO mice (measured by pregnancy rate) was only mildly affected in the short term and unaffected in the long term (70% vs 30% reduction in the short term, and 50 vs 0% in the long term, respectively). Immunobiologic analysis revealed that the diminished capacity of CCR5KO to control acute chlamydial infection correlated with the relatively low chemokine [interferon-inducible protein 10 (IP-10) and regulated upon activation normal cell expressed and secreted (RANTES)] and cytokine (mainly interferon-gamma and tumor necrosis factor-alpha) expression corresponding to a poor early T-helper I response. However, the reduced incidence of complications in the CCR5KO mice appears to correlate with the low activity of long term inflammatory mediators. Besides, the translational studies in humans revealed that among patients with positive anti-chlamydial IgG responses, tubal pathology correlated with a low incidence of CCR5delta32 deletion (7%), while women without tubal pathology had higher incidence of the CCR5delta32 deletion (31%) as compared to controls (19%). Thus, in mice and humans the inflammation associated with CCR5 function may predispose to development of complications of chlamydial infection, such as TFI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118671

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  18 in total

Review 1.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies.

Authors:  Jun Zhang; Eileen Rao; Marianna Dioszegi; Rama Kondru; Andre DeRosier; Eva Chan; Stephan Schwoerer; Nick Cammack; Michael Brandt; Surya Sankuratri; Changhua Ji
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

3.  Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.

Authors:  Hervé C Gérard; Jessica A Stanich; Cynthia E Oszust; Judith A Whittum-Hudson; John D Carter; H Ralph Schumacher; Alan P Hudson
Journal:  Am J Med Sci       Date:  2010-12       Impact factor: 2.378

4.  Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5.

Authors:  S Sorce; J Bonnefont; S Julien; N Marq-Lin; I Rodriguez; M Dubois-Dauphin; K H Krause
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

5.  Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.

Authors:  Suzan Dziennis; Sarah Mader; Kozaburo Akiyoshi; Xuefang Ren; Patricia Ayala; Gregory G Burrows; Arthur A Vandenbark; Paco S Herson; Patricia D Hurn; Halina A Offner
Journal:  Metab Brain Dis       Date:  2011-04-07       Impact factor: 3.584

6.  Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Authors:  Rhea N Coler; Ajay Bhatia; Jean-Francois Maisonneuve; Peter Probst; Brenda Barth; Pamela Ovendale; Hang Fang; Mark Alderson; Yves Lobet; Joe Cohen; Pascal Mettens; Steven G Reed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

7.  Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Authors:  Joseph U Igietseme; Qing He; Kahaliah Joseph; Francis O Eko; Deborah Lyn; Godwin Ananaba; Angela Campbell; Claudiu Bandea; Carolyn M Black
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

8.  CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.

Authors:  David C Gondek; Andrew J Olive; Georg Stary; Michael N Starnbach
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

9.  MiR-378b Modulates Chlamydia-Induced Upper Genital Tract Pathology.

Authors:  Stephanie R Lundy; Kobe Abney; Debra Ellerson; Joseph U Igietseme; Darin Carroll; Francis O Eko; Yusuf O Omosun
Journal:  Pathogens       Date:  2021-05-07

10.  Unveiling New Molecular Factors Useful for Detection of Pelvic Inflammatory Disease due to Chlamydia trachomatis Infection.

Authors:  Carmen Rodriguez-Cerdeira; Elena Sanchez-Blanco; Alberto Molares-Vila; Alfonso Alba
Journal:  ISRN Obstet Gynecol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.